Drug Profile
Aspirin/sumatriptan
Alternative Names: Aspirin/sumatriptan 325/12.5; VVD 101Latest Information Update: 29 Sep 2021
Price :
$50
*
At a glance
- Originator Vivid Pharma Inc
- Class Antimigraines; Indoles; Nonsteroidal anti-inflammatories; Salicylic acids; Small molecules; Sulfonamides; Tryptamines
- Mechanism of Action 5-HT1 serotonin receptor agonists; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Headache
Most Recent Events
- 29 Sep 2021 Discontinued - Phase-II for Headache in USA (PO)
- 11 Apr 2017 Suspended - Phase-II for Headache (delayed alcohol induced) in USA (PO)
- 01 Jan 2016 Vivid Pharma completes a phase II trial in Headache (delayed alcohol indced) in USA (NCT02176655)